Log In
Print
BCIQ
Print
Print this Print this
 

Cortiment MMX (Budesonide MMX, Uceris)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals S.p.A.
DescriptionBudesonide delivered using MMX multi-matrix system technology
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationInflammatory bowel disease (IBD)
Partner

Ferring Pharmaceuticals A/S; Santarus Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today